Clinical Trial Update: Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase II neoadjuvant trial of continuous infusion paclitaxel plus cisplatin, followed by chest radiotherapy, in stage III non-small cell lung cancer has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cisplatin (Platinol) (cisplatin)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms | Phase 2 | Status: COMPLETED